{"id":398,"date":"2017-04-27T08:38:46","date_gmt":"2017-04-27T08:38:46","guid":{"rendered":"https:\/\/blogeurekers.mercalabs.com\/?p=398"},"modified":"2022-03-03T08:28:20","modified_gmt":"2022-03-03T08:28:20","slug":"recordati-cotizada-europea-comprometida-con-enferemedades-raras","status":"publish","type":"post","link":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras","title":{"rendered":"Recordati: una cotizada europea alcista comprometida con las enfermedades raras"},"content":{"rendered":"<p><strong>Recordati S.p.A\u00a0<\/strong>\u00a0es un grupo empresarial italiano fundado en 1926 y dedicado a la\u00a0<span lang=\"es\"><span title=\"con pi\u00f9 di 4.100 dipendenti, che si dedica alla ricerca, allo sviluppo, alla produzione e alla commercializzazione di prodotti farmaceutici.\">investigaci\u00f3n, el desarrollo, la fabricaci\u00f3n y la comercializaci\u00f3n de productos farmac\u00e9uticos. Tiene<\/span><\/span>\u00a0 presencia activa en los principales pa\u00edses europeos, as\u00ed como en Rusia, Turqu\u00eda, el norte de \u00c1frica, Estados Unidos y algunos pa\u00edses de Sudam\u00e9rica. Adem\u00e1s,\u00a0<strong>cotiza en la bolsa de Mil\u00e1n desde 1984 bajo el ticker REC.MI y, hasta la fecha de hoy, se ha revalorizado m\u00e1s de un 3.000%<\/strong>.<\/p>\n<p>Pero, quiz\u00e1s, uno de los aspectos m\u00e1s destacados de su larga y pr\u00f3spera trayectoria como empresa es\u00a0<strong>su compromiso con el diagn\u00f3stico y la gesti\u00f3n de las enfermedades raras, las cuales se cifran actualmente en 7.000<\/strong>, aunque, debido a su baja incidencia para la industria farmac\u00e9utica &#8211; menos de 5 afectados por cada 10.000 habitantes-,\u00a0<strong>solo 300 de ellas cuentan con un tratamiento<\/strong>.<\/p>\n<p>Bajo la convicci\u00f3n de que \u00abtoda persona con una enfermedad rara tiene derecho al mejor tratamiento\u00bb,\u00a0<strong>en 2007, Recordati adquiri\u00f3\u00a0<span style=\"color: #00add9;\"><a class=\"external-link\" style=\"color: #00add9;\" href=\"http:\/\/www.orphan-europe.com\/\" rel=\"nofollow\">Orphan Europe<\/a><\/span>, un grupo farmac\u00e9utico con sede en Par\u00eds especializado en este tipo de enfermedades<\/strong>\u00a0y que cuenta con personal distribuido en 30 pa\u00edses para crear redes de trabajo y una infraestructura que permita la producci\u00f3n, el envasado y la distribuci\u00f3n de un n\u00famero muy peque\u00f1o de los llamados \u00abmedicamentos hu\u00e9rfanos\u00bb a personas afectadas en todo el mundo.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.<\/p>\n","protected":false},"author":4,"featured_media":399,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[107],"tags":[6,12,51,127,128],"class_list":["post-398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-bolsa","tag-rentabilidad","tag-curiosidades","tag-recordati","tag-cotizacion"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Recordati, el gigante comprometido con las enfermedades raras - Eurekers<\/title>\n<meta name=\"description\" content=\"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recordati, el gigante comprometido con las enfermedades raras - Eurekers\" \/>\n<meta property=\"og:description\" content=\"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\" \/>\n<meta property=\"og:site_name\" content=\"Blog de Bolsa - Eurekers\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eurekersbolsa\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-27T08:38:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-03T08:28:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png\" \/>\n\t<meta property=\"og:image:width\" content=\"726\" \/>\n\t<meta property=\"og:image:height\" content=\"275\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nieves P\u00e9rez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@eurekersbolsa\" \/>\n<meta name=\"twitter:site\" content=\"@eurekersbolsa\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nieves P\u00e9rez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\"},\"author\":{\"name\":\"Nieves P\u00e9rez\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/9d6ad3114551dae337863d4e21d4437f\"},\"headline\":\"Recordati: una cotizada europea alcista comprometida con las enfermedades raras\",\"datePublished\":\"2017-04-27T08:38:46+00:00\",\"dateModified\":\"2022-03-03T08:28:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\"},\"wordCount\":246,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png\",\"keywords\":[\"bolsa\",\"rentabilidad\",\"curiosidades\",\"recordati\",\"cotizaci\u00f3n\"],\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\",\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\",\"name\":\"Recordati, el gigante comprometido con las enfermedades raras - Eurekers\",\"isPartOf\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png\",\"datePublished\":\"2017-04-27T08:38:46+00:00\",\"dateModified\":\"2022-03-03T08:28:20+00:00\",\"description\":\"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage\",\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png\",\"contentUrl\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png\",\"width\":726,\"height\":275},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.eurekers.com\/cursosbolsa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recordati: una cotizada europea alcista comprometida con las enfermedades raras\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#website\",\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/\",\"name\":\"Blog de Bolsa - Eurekers\",\"description\":\"Formaci\u00f3n y Comunidad de Bolsa\",\"publisher\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eurekers.com\/cursosbolsa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#organization\",\"name\":\"Eurekers.com\",\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/10\/Anagrama.png\",\"contentUrl\":\"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/10\/Anagrama.png\",\"width\":296,\"height\":274,\"caption\":\"Eurekers.com\"},\"image\":{\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/eurekersbolsa\",\"https:\/\/x.com\/eurekersbolsa\",\"https:\/\/www.instagram.com\/eurekers\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/9d6ad3114551dae337863d4e21d4437f\",\"name\":\"Nieves P\u00e9rez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4de60f2ef1369fd2f965547edc968c6e?s=96&d=wp_user_avatar&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4de60f2ef1369fd2f965547edc968c6e?s=96&d=wp_user_avatar&r=g\",\"caption\":\"Nieves P\u00e9rez\"},\"sameAs\":[\"http:\/\/eurekers.com\"],\"url\":\"https:\/\/www.eurekers.com\/cursosbolsa\/author\/nievesperez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recordati, el gigante comprometido con las enfermedades raras - Eurekers","description":"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras","og_locale":"es_ES","og_type":"article","og_title":"Recordati, el gigante comprometido con las enfermedades raras - Eurekers","og_description":"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.","og_url":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras","og_site_name":"Blog de Bolsa - Eurekers","article_publisher":"https:\/\/www.facebook.com\/eurekersbolsa","article_published_time":"2017-04-27T08:38:46+00:00","article_modified_time":"2022-03-03T08:28:20+00:00","og_image":[{"width":726,"height":275,"url":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png","type":"image\/png"}],"author":"Nieves P\u00e9rez","twitter_card":"summary_large_image","twitter_creator":"@eurekersbolsa","twitter_site":"@eurekersbolsa","twitter_misc":{"Escrito por":"Nieves P\u00e9rez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#article","isPartOf":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras"},"author":{"name":"Nieves P\u00e9rez","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/9d6ad3114551dae337863d4e21d4437f"},"headline":"Recordati: una cotizada europea alcista comprometida con las enfermedades raras","datePublished":"2017-04-27T08:38:46+00:00","dateModified":"2022-03-03T08:28:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras"},"wordCount":246,"commentCount":0,"publisher":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#organization"},"image":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage"},"thumbnailUrl":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png","keywords":["bolsa","rentabilidad","curiosidades","recordati","cotizaci\u00f3n"],"articleSection":["Noticias"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras","url":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras","name":"Recordati, el gigante comprometido con las enfermedades raras - Eurekers","isPartOf":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage"},"image":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage"},"thumbnailUrl":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png","datePublished":"2017-04-27T08:38:46+00:00","dateModified":"2022-03-03T08:28:20+00:00","description":"Recordati es una empresa muy potenten comprometida con las enfermedades raras, y se ha dedicado a investigarlas y tratarlas.","breadcrumb":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#primaryimage","url":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png","contentUrl":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/12\/Recordati_cotizada_enfermedades_raras.png","width":726,"height":275},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/recordati-cotizada-europea-comprometida-con-enferemedades-raras#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.eurekers.com\/cursosbolsa\/"},{"@type":"ListItem","position":2,"name":"Recordati: una cotizada europea alcista comprometida con las enfermedades raras"}]},{"@type":"WebSite","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#website","url":"https:\/\/www.eurekers.com\/cursosbolsa\/","name":"Blog de Bolsa - Eurekers","description":"Formaci\u00f3n y Comunidad de Bolsa","publisher":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurekers.com\/cursosbolsa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#organization","name":"Eurekers.com","url":"https:\/\/www.eurekers.com\/cursosbolsa\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/10\/Anagrama.png","contentUrl":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-content\/uploads\/2018\/10\/Anagrama.png","width":296,"height":274,"caption":"Eurekers.com"},"image":{"@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eurekersbolsa","https:\/\/x.com\/eurekersbolsa","https:\/\/www.instagram.com\/eurekers\/"]},{"@type":"Person","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/9d6ad3114551dae337863d4e21d4437f","name":"Nieves P\u00e9rez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eurekers.com\/cursosbolsa\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4de60f2ef1369fd2f965547edc968c6e?s=96&d=wp_user_avatar&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4de60f2ef1369fd2f965547edc968c6e?s=96&d=wp_user_avatar&r=g","caption":"Nieves P\u00e9rez"},"sameAs":["http:\/\/eurekers.com"],"url":"https:\/\/www.eurekers.com\/cursosbolsa\/author\/nievesperez"}]}},"_links":{"self":[{"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/posts\/398"}],"collection":[{"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/comments?post=398"}],"version-history":[{"count":3,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/posts\/398\/revisions"}],"predecessor-version":[{"id":103643,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/posts\/398\/revisions\/103643"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/media\/399"}],"wp:attachment":[{"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/media?parent=398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/categories?post=398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurekers.com\/cursosbolsa\/wp-json\/wp\/v2\/tags?post=398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}